Jinyu Historical Cash Flow

600201 Stock   7.37  0.05  0.68%   
Analysis of Jinyu Bio cash flow over time is an excellent tool to project Jinyu Bio Technology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 166.3 M or Total Cash From Operating Activities of 401.7 M as it is a great indicator of Jinyu Bio ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Jinyu Bio Technology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jinyu Bio Technology is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Jinyu Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Jinyu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jinyu's non-liquid assets can be easily converted into cash.

Jinyu Bio Cash Flow Chart

At present, Jinyu Bio's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Investing Activities is expected to grow to about 43.3 M, whereas Other Cashflows From Financing Activities is forecasted to decline to (5.6 M).

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Jinyu Bio Technology to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jinyu Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Jinyu Bio Technology financial statement analysis. It represents the amount of money remaining after all of Jinyu Bio Technology Co operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Jinyu Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jinyu Bio Technology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, Jinyu Bio's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Investing Activities is expected to grow to about 43.3 M, whereas Other Cashflows From Financing Activities is forecasted to decline to (5.6 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures372.7M190.1M273.2M166.3M
Dividends Paid134.2M124.4M66.8M104.3M

Jinyu Bio cash flow statement Correlations

-0.730.71-0.19-0.04-0.53-0.50.230.470.060.07-0.67-0.64-0.46-0.420.010.07
-0.73-0.70.320.30.380.47-0.18-0.530.12-0.340.490.430.530.250.150.06
0.71-0.7-0.32-0.41-0.18-0.5-0.190.65-0.460.51-0.23-0.11-0.370.070.210.15
-0.190.32-0.32-0.15-0.10.720.02-0.160.55-0.59-0.02-0.050.190.07-0.3-0.28
-0.040.3-0.41-0.150.38-0.260.08-0.530.2-0.560.05-0.33-0.08-0.250.260.36
-0.530.38-0.18-0.10.380.06-0.11-0.64-0.180.010.470.310.270.150.160.18
-0.50.47-0.50.72-0.260.060.28-0.420.59-0.33-0.010.160.55-0.09-0.55-0.47
0.23-0.18-0.190.020.08-0.110.28-0.460.69-0.08-0.72-0.560.17-0.84-0.75-0.34
0.47-0.530.65-0.16-0.53-0.64-0.42-0.46-0.530.4-0.020.09-0.420.390.320.24
0.060.12-0.460.550.2-0.180.590.69-0.53-0.7-0.59-0.650.03-0.69-0.75-0.6
0.07-0.340.51-0.59-0.560.01-0.33-0.080.4-0.70.090.490.240.180.230.21
-0.670.49-0.23-0.020.050.47-0.01-0.72-0.02-0.590.090.820.130.890.50.4
-0.640.43-0.11-0.05-0.330.310.16-0.560.09-0.650.490.820.530.770.450.33
-0.460.53-0.370.19-0.080.270.550.17-0.420.030.240.130.53-0.060.090.09
-0.420.250.070.07-0.250.15-0.09-0.840.39-0.690.180.890.77-0.060.520.41
0.010.150.21-0.30.260.16-0.55-0.750.32-0.750.230.50.450.090.520.72
0.070.060.15-0.280.360.18-0.47-0.340.24-0.60.210.40.330.090.410.72
Click cells to compare fundamentals

Jinyu Bio Account Relationship Matchups

Jinyu Bio cash flow statement Accounts

201920202021202220232024 (projected)
Other Cashflows From Financing Activities(259.7M)(480.6M)36.5M(6.0M)(5.4M)(5.6M)
Dividends Paid403.4M67.1M134.2M124.4M66.8M104.3M
Capital Expenditures307.4M228.3M372.7M190.1M273.2M166.3M
Total Cash From Operating Activities405.2M699.6M533.1M344.7M414.8M401.7M
Change To Account Receivables143.5M(61.9M)(125.1M)(70.2M)(63.2M)(60.0M)
Net Income221.0M406.2M382.3M210.7M283.6M263.7M
Total Cash From Financing Activities(846.5M)20.9M(123.3M)(437.3M)(393.6M)(373.9M)
Other Cashflows From Investing Activities39.8M45.2M10.2M35.9M41.3M43.3M
Change To Inventory27.4M(112.1M)25.9M(20.5M)8.5M9.0M
Total Cashflows From Investing Activities413.1M(385.7M)(548.1M)176.6M203.1M213.3M
Investments680.1M(205.0M)(66.1M)210.6M(740.1M)(703.1M)
Change In Cash(28.1M)334.6M(138.4M)84.1M(213.9M)(203.2M)
Net Borrowings37.5M(40.1M)(504.7K)59.2M68.1M71.5M
Depreciation107.1M173.6M191.6M196.9M189.3M140.3M
Change To Operating Activities58.6M7.0M5.7M11.1M10.0M9.5M
Change To Netincome52.8M(382.5K)46.7M51.4M59.1M62.1M
Change To Liabilities(154.0M)288.0M362.7K(27.2M)(24.5M)(23.3M)
End Period Cash Flow986.4M1.3B1.2B1.3B1.1B1.1B
Free Cash Flow97.9M471.3M160.4M154.5M141.7M159.1M
Change In Working Capital8.5M104.5M(98.9M)(117.9M)(142.8M)(149.9M)
Begin Period Cash Flow1.0B986.4M1.3B1.2B1.3B1.1B
Other Non Cash Items9.7M1.8M(13.5M)(27.9M)(32.1M)(30.5M)

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

The Cash Flow Statement is a financial statement that shows how changes in Jinyu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jinyu's non-liquid assets can be easily converted into cash.